Yes, impetigo readily spreads to different body parts on the same patient through autoinoculation, and this is a well-documented natural progression of the infection.
Impetigo characteristically spreads from one body site to another in a predictable pattern, making prompt treatment essential to prevent dissemination.
How Impetigo Spreads on the Body
The natural history of impetigo demonstrates a clear site-to-site progression:
- Streptococcal impetigo spreads in the following sequence: normal skin → skin lesions → respiratory tract 1
- Streptococci colonize normal skin an average of 10 days before lesions develop 1
- Once a streptococcal serotype is recovered from normal skin, there is a 76% risk of developing lesions from that same type 1
The mechanism of spread is autoinoculation - patients transfer bacteria from existing lesions to other body sites through scratching, touching, or contact with contaminated materials. This is why the IDSA guidelines emphasize that oral therapy is recommended for patients with numerous lesions, specifically to help decrease transmission 2.
Clinical Implications for Spread
Distribution Patterns
- While 62% of lesions occur on the legs, streptococci can be recovered from multiple sites including wrists, ankles, and back with similar frequency (28-37%) 1
- Primary lesions on the face are strongly associated with nasal carriage of S. aureus (93% of facial impetigo patients had nasal SA vs 74% with lesions elsewhere) 3
- The homology between nasal and skin isolates is remarkably high - 87% of patients had identical strains in nose and skin lesions 3
Timeline of Spread
- New body sites become infected rapidly - secondary skin acquisition occurs within an average of 4.8 days 1
- However, the full spread pattern can take up to 21 days from first appearance to last acquisition of skin disease 1
Treatment Strategy to Prevent Spread
Oral antibiotics are specifically recommended over topical therapy when multiple lesions are present to halt the spread pattern 2:
- Topical therapy (mupirocin or retapamulin for 5 days) is appropriate for limited disease
- Oral therapy (7-day course) should be used for:
- Patients with numerous lesions
- Outbreaks affecting multiple people
- To decrease transmission of infection
The recommended oral agents are dicloxacillin or cephalexin (targeting methicillin-susceptible S. aureus), or doxycycline, clindamycin, or TMP-SMX when MRSA is suspected 2.
Key Pitfall to Avoid
Do not assume impetigo will remain localized. The natural history shows that 74% of episodes involve spread from normal skin colonization to lesions, and the infection continues to disseminate without treatment 1. Patients should not return to work or school until 12-24 hours after initiating antibiotics to prevent both person-to-person and autoinoculation spread 4.
Good hand hygiene and thoroughly washing objects used by infected individuals are essential to prevent continued autoinoculation to new body sites 4.